Neurocrine Bio. (NBIX) PT Raised to $120 at SVB Leerink
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $138.94 --0%
Rating Summary:
31 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 2 | New: 10
Rating Summary:
31 Buy, 6 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 2 | New: 10
Join SI Premium – FREE
SVB Leerink analyst Marc Goodman raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $120.00 (from $105.00) while maintaining a Market Perform rating.
You May Also Be Interested In
- Neurocrine Bio. (NBIX) PT Lowered to $187 at RBC Capital
- AxoGen, Inc. (AXGN) PT Raised to $53 at Raymond James
- JPMorgan Assumes Kingdee Int'l Software Group Co. (268:HK) (KGDEF) at Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
